Free tool
Oncology stocks
We cover 31 companies grouped under the Oncology theme. The median market value in the group is $50.63M. Across the group, the median move over the past trading day is 0.00%. 30% of the 30 with a 200-day average trade above it. Price change over the past year runs from −72.3% to +81.9% across the middle 80 percent of the group, with a median of −25.6%.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
31 of 319 companies match these filters.Clear filters
| Ticker | Company | Price | 1M return | YTD return | 1Y return |
|---|---|---|---|---|---|
| 2160.T | GNI Group Ltd. | 2,879.00 JPY | +25.17% | +25.72% | +8.36% |
| 4587.T | PeptiDream Inc. | 1,107.50 JPY | +16.74% | −31.68% | −27.31% |
| 4588.T | Oncolys BioPharma Inc. | 4,080.00 JPY | +66.46% | +173.09% | +539.50% |
| CU6.AX | Clarity Pharmaceuticals Ltd | 2.37 AUD | +13.16% | −36.25% | −25.63% |
| RAC.AX | Racura Oncology Ltd | 2.23 AUD | +12.06% | −22.30% | +87.39% |
| SPL.AX | Starpharma Holdings Limited | 0.73 AUD | −2.03% | +98.63% | +437.04% |
| 4889.T | Renascience Inc. | 1,309.00 JPY | −8.59% | −8.40% | −40.80% |
| 4575.T | CanBas Co., Ltd. | 840.00 JPY | +23.17% | +2.56% | −30.98% |
| 4579.T | RaQualia Pharma Inc. | 568.00 JPY | +25.39% | −41.56% | +3.46% |
| 4888.T | Stella Pharma Corporation | 353.00 JPY | +18.06% | +66.51% | −11.75% |
| 4564.T | OncoTherapy Science, Inc. | 21.00 JPY | +5.00% | 0.00% | −25.00% |
| ATX.AX | Amplia Therapeutics Limited | 0.15 AUD | +11.54% | −14.71% | −14.71% |
| IMM.AX | Immutep Limited | 0.05 AUD | +8.51% | −88.14% | −79.18% |
| 4572.T | Carna Biosciences, Inc. | 402.00 JPY | +37.67% | 0.00% | +81.90% |
| 4597.T | Solasia Pharma K.K. | 30.00 JPY | +3.45% | +7.14% | −18.92% |
| PTX.AX | Prescient Therapeutics Limited | 0.07 AUD | −17.28% | −19.28% | +63.41% |
| 4594.T | BrightPath Biotherapeutics Co., Ltd. | 53.00 JPY | +15.22% | +8.16% | −39.08% |
| 4583.T | Chiome Bioscience Inc. | 86.00 JPY | +26.47% | −19.63% | −36.76% |
| 206A.T | PRISM BioLab Co.,LTD | 170.00 JPY | +18.06% | +5.59% | −5.56% |
| SNT.AX | Syntara Limited | 0.03 AUD | +22.73% | −20.59% | +1.89% |
| 190A.T | CHORDIA THERAPEUTICS INC | 72.00 JPY | −1.37% | −35.71% | −59.32% |
| 4582.T | SymBio Pharmaceuticals Limited | 63.00 JPY | −4.55% | −30.00% | −57.43% |
| IMU.AX | Imugene Limited | 0.07 AUD | −17.65% | −82.05% | −75.00% |
| NOX.AX | Noxopharm Limited | 0.09 AUD | −2.17% | −4.26% | −10.00% |
| 4882.T | Perseus Proteomics Inc. | 149.00 JPY | +4.93% | −34.65% | −56.56% |
| RAD.AX | Radiopharm Theranostics Limited | 0.01 AUD | −28.57% | −60.00% | −63.64% |
| 4598.T | Delta-Fly Pharma, Inc. | 104.00 JPY | +9.47% | −80.92% | −81.75% |
| PAB.AX | Patrys Limited | 0.03 AUD | −23.08% | +11.11% | −14.29% |
| PER.AX | PERCHERON FPO [PER] | 0.01 AUD | +66.67% | −47.37% | −54.55% |
| IVX.AX | Invion Limited | 0.04 AUD | −18.18% | −61.29% | −72.31% |
| NX1.AX | Nexalis Therapeutics Limited | 0.01 AUD | 0.00% | −50.00% | −50.00% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.